Comparing a head-mounted virtual reality perimeter and the Humphrey Field Analyzer for visual field testing in healthy and glaucoma patients.


Journal

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
ISSN: 1475-1313
Titre abrégé: Ophthalmic Physiol Opt
Pays: England
ID NLM: 8208839

Informations de publication

Date de publication:
Jan 2024
Historique:
revised: 16 08 2023
received: 25 06 2023
accepted: 23 08 2023
medline: 17 12 2023
pubmed: 7 10 2023
entrez: 7 10 2023
Statut: ppublish

Résumé

To compare clinical visual field outputs in glaucoma and healthy patients returned by the Humphrey Field Analyzer (HFA) and virtual reality (Virtual Field, VF) perimetry. One eye of 54 glaucoma patients and 41 healthy subjects was prospectively tested (three times each in random order) using the HFA and VF perimeters (24-2 test grids). We extracted and compared global indices (mean deviation [MD] and pattern standard deviation [PSD]), pointwise sensitivity (and calculated 'equivalent' sensitivity after accounting for differences in background luminance) and pointwise defects. Bland-Altman (mean difference [M The VF test was shorter (by 76 s) and had lower fixation losses (by 0.08) and false-positive rate (by 0.01) compared to the HFA (all p < 0.0001). Intraclass correlations were 0.86, 0.82 and 0.47 for MD, PSD and pointwise sensitivity between devices, respectively. Test-retest variability was higher for VF (M Virtual Field returns global results that are correlated with the HFA, but pointwise sensitivities were more variable. Differences in test-retest variability and defect detection by its current normative database raise questions about the widespread adoption of VF in lieu of the HFA.

Identifiants

pubmed: 37803502
doi: 10.1111/opo.13229
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-95

Subventions

Organisme : National Health and Medical Research Council
ID : 1186915

Informations de copyright

© 2023 The Authors. Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists.

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Am J Ophthalmol. 2019 Feb;198:154-165
pubmed: 30336129
Am J Ophthalmol. 2022 Feb;234:91-98
pubmed: 34280366
Transl Vis Sci Technol. 2016 May 20;5(3):10
pubmed: 27247858
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):439-445
pubmed: 29356822
Clin Exp Ophthalmol. 2023 Mar;51(2):162-169
pubmed: 36751125
Ophthalmology. 2020 Sep;127(9):1258
pubmed: 32535062
Am J Ophthalmol. 2006 Jan;141(1):24-30
pubmed: 16386972
Clin Ophthalmol. 2017 Aug 07;11:1431-1443
pubmed: 28848325
Am J Ophthalmol. 2021 Oct;230:48-59
pubmed: 33951444
Clin Exp Optom. 2017 Jul;100(4):313-332
pubmed: 28640951
Vision Res. 2000;40(19):2579-88
pubmed: 10958910
Graefes Arch Clin Exp Ophthalmol. 1990;228(4):321-5
pubmed: 2401415
Ophthalmic Physiol Opt. 2022 Sep;42(5):973-985
pubmed: 35598152
J Curr Glaucoma Pract. 2019 Sep-Dec;13(3):83-87
pubmed: 32431476
Ophthalmol Sci. 2021 Jun 25;1(2):100035
pubmed: 36249304
J Glaucoma. 2021 Jan 1;30(1):17-23
pubmed: 32941320
Clin Exp Ophthalmol. 2010 Apr;38(3):273-6
pubmed: 20447123
Opt Express. 2022 Dec 5;30(25):44918-44932
pubmed: 36522905
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5631-5636
pubmed: 27784065
Transl Vis Sci Technol. 2021 Oct 4;10(12):10
pubmed: 34614166
Ophthalmol Glaucoma. 2023 Mar-Apr;6(2):121-128
pubmed: 35577312
J Ophthalmic Vis Res. 2022 Jan 21;17(1):33-41
pubmed: 35194494
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1854-62
pubmed: 15161850
Am J Ophthalmol. 2022 Jan;233:180-188
pubmed: 34283973
Clin Exp Optom. 2021 Aug;104(6):728-733
pubmed: 34016029
Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
pubmed: 12049575
Ophthalmic Physiol Opt. 2024 Jan;44(1):83-95
pubmed: 37803502
Surv Ophthalmol. 2022 Sep-Oct;67(5):1516-1530
pubmed: 35181279
Psychometrika. 1947 Jun;12(2):153-7
pubmed: 20254758
Transl Vis Sci Technol. 2022 Feb 01;11(2):20
pubmed: 35142783
Am J Ophthalmol. 2018 Jun;190:9-16
pubmed: 29550190
Ophthalmology. 2011 May;118(5):986-1002
pubmed: 21539982
Ophthalmologe. 2005 Jun;102(6):627-44; quiz 645-6
pubmed: 15906041
J Glaucoma. 2020 Feb;29(2):86-91
pubmed: 31790067
JAMA Ophthalmol. 2015 Jan;133(1):74-80
pubmed: 25340390
Acta Ophthalmol (Copenh). 1975 Jun;53(3):293-310
pubmed: 1174394
Ophthalmology. 2014 Jul;121(7):1359-69
pubmed: 24629617
Ophthalmology. 2021 Jan;128(1):P71-P150
pubmed: 34933745
Curr Opin Ophthalmol. 2021 Mar 1;32(2):92-97
pubmed: 33443958
Arch Ophthalmol. 1986 May;104(5):712-7
pubmed: 3707412
Am J Ophthalmol. 2019 Dec;208:251-264
pubmed: 31470001
J Opt Soc Am. 1948 Feb;38(2):196-208
pubmed: 18901781
J Comp Neurol. 2019 Jan 1;527(1):87-116
pubmed: 27447117
J Glaucoma. 2016 Jun;25(6):539-46
pubmed: 26091178

Auteurs

Jack Phu (J)

School of Optometry and Vision Science, University of New South Wales Sydney, Kensington, New South Wales, Australia.
Centre for Eye Health, University of New South Wales Sydney, Kensington, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
Concord Clinical School, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
School of Medicine (Optometry), Deakin University, Waurn Ponds, Victoria, Australia.

Henrietta Wang (H)

School of Optometry and Vision Science, University of New South Wales Sydney, Kensington, New South Wales, Australia.
Centre for Eye Health, University of New South Wales Sydney, Kensington, New South Wales, Australia.

Michael Kalloniatis (M)

School of Optometry and Vision Science, University of New South Wales Sydney, Kensington, New South Wales, Australia.
School of Medicine (Optometry), Deakin University, Waurn Ponds, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH